位置:首页 > 蛋白库 > MFN2_MOUSE
MFN2_MOUSE
ID   MFN2_MOUSE              Reviewed;         757 AA.
AC   Q80U63; A2A7Y7; A8Y5E4; Q3V3B8; Q80WP4; Q80XK3; Q8BHF0; Q8BKV5; Q8R535;
AC   Q923X2;
DT   24-MAY-2004, integrated into UniProtKB/Swiss-Prot.
DT   24-MAY-2004, sequence version 3.
DT   03-AUG-2022, entry version 158.
DE   RecName: Full=Mitofusin-2;
DE            EC=3.6.5.- {ECO:0000250|UniProtKB:O95140};
DE   AltName: Full=Hypertension-related protein 1;
DE   AltName: Full=Mitochondrial assembly regulatory factor;
DE            Short=HSG protein;
DE   AltName: Full=Transmembrane GTPase MFN2;
GN   Name=Mfn2; Synonyms=Kiaa0214, Marf;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, DISRUPTION PHENOTYPE,
RP   MULTIMERIZATION, AND SUBUNIT.
RC   STRAIN=FVB/NJ;
RX   PubMed=12527753; DOI=10.1083/jcb.200211046;
RA   Chen H., Detmer S.A., Ewald A.J., Griffin E.E., Fraser S.E., Chan D.C.;
RT   "Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and
RT   are essential for embryonic development.";
RL   J. Cell Biol. 160:189-200(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=12598526; DOI=10.1074/jbc.m212754200;
RA   Bach D., Pich S., Soriano F.X., Vega N., Baumgartner B., Oriola J.,
RA   Daugaard J.R., Lloberas J., Camps M., Zierath J.R., Rabasa-Lhoret R.,
RA   Wallberg-Henriksson H., Laville M., Palacin M., Vidal H., Rivera F.,
RA   Brand M., Zorzano A.;
RT   "Mitofusin-2 determines mitochondrial network architecture and
RT   mitochondrial metabolism. A novel regulatory mechanism altered in
RT   obesity.";
RL   J. Biol. Chem. 278:17190-17197(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Honda S., Hirose S.;
RT   "Characterization of mouse fzo.";
RL   Submitted (SEP-2000) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RC   STRAIN=BALB/cJ;
RX   PubMed=15322553; DOI=10.1038/ncb1161;
RA   Chen K.-H., Guo X., Ma D., Guo Y., Li Q., Yang D., Li P., Qiu X., Wen S.,
RA   Xiao R.-P., Tang J.;
RT   "Dysregulation of HSG triggers vascular proliferative disorders.";
RL   Nat. Cell Biol. 6:872-883(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=12693553; DOI=10.1093/dnares/10.1.35;
RA   Okazaki N., Kikuno R., Ohara R., Inamoto S., Aizawa H., Yuasa S.,
RA   Nakajima D., Nagase T., Ohara O., Koga H.;
RT   "Prediction of the coding sequences of mouse homologues of KIAA gene: II.
RT   The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs
RT   identified by screening of terminal sequences of cDNA clones randomly
RT   sampled from size-fractionated libraries.";
RL   DNA Res. 10:35-48(2003).
RN   [6]
RP   SEQUENCE REVISION.
RA   Okazaki N., Kikuno R., Nagase T., Ohara O., Koga H.;
RL   Submitted (AUG-2003) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   STRAIN=C57BL/6J; TISSUE=Kidney, and Thymus;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   STRAIN=FVB/N; TISSUE=Salivary gland;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   PROTEIN SEQUENCE OF 421-428, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   STRAIN=C57BL/6J; TISSUE=Brain;
RA   Lubec G., Kang S.U.;
RL   Submitted (APR-2007) to UniProtKB.
RN   [11]
RP   TISSUE SPECIFICITY.
RX   PubMed=11950885; DOI=10.1242/jcs.115.8.1663;
RA   Rojo M., Legros F., Chateau D., Lombes A.;
RT   "Membrane topology and mitochondrial targeting of mitofusins, ubiquitous
RT   mammalian homologs of the transmembrane GTPase Fzo.";
RL   J. Cell Sci. 115:1663-1674(2002).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-442, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, Brown adipose tissue, Heart, Kidney, Liver, Lung, Spleen, and
RC   Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [13]
RP   FUNCTION IN UPR, AND INTERACTION WITH EIF2AK3.
RX   PubMed=23921556; DOI=10.1038/emboj.2013.168;
RA   Munoz J.P., Ivanova S., Sanchez-Wandelmer J., Martinez-Cristobal P.,
RA   Noguera E., Sancho A., Diaz-Ramos A., Hernandez-Alvarez M.I., Sebastian D.,
RA   Mauvezin C., Palacin M., Zorzano A.;
RT   "Mfn2 modulates the UPR and mitochondrial function via repression of
RT   PERK.";
RL   EMBO J. 32:2348-2361(2013).
RN   [14]
RP   FUNCTION.
RX   PubMed=23921378; DOI=10.1074/jbc.m113.479873;
RA   Palmer C.S., Elgass K.D., Parton R.G., Osellame L.D., Stojanovski D.,
RA   Ryan M.T.;
RT   "MiD49 and MiD51 can act independently of Mff and Fis1 in Drp1 recruitment
RT   and are specific for mitochondrial fission.";
RL   J. Biol. Chem. 288:27584-27593(2013).
RN   [15]
RP   FUNCTION IN MITOPHAGY, INTERACTION WITH PRKN, PHOSPHORYLATION AT THR-111
RP   AND SER-442, UBIQUITINATION BY PRKN, SUBCELLULAR LOCATION, AND DISRUPTION
RP   PHENOTYPE.
RX   PubMed=23620051; DOI=10.1126/science.1231031;
RA   Chen Y., Dorn G.W. II;
RT   "PINK1-phosphorylated mitofusin 2 is a Parkin receptor for culling damaged
RT   mitochondria.";
RL   Science 340:471-475(2013).
RN   [16]
RP   UBIQUITINATION, AND DEUBIQUITINATION.
RX   PubMed=24513856; DOI=10.1038/cr.2014.20;
RA   Yue W., Chen Z., Liu H., Yan C., Chen M., Feng D., Yan C., Wu H., Du L.,
RA   Wang Y., Liu J., Huang X., Xia L., Liu L., Wang X., Jin H., Wang J.,
RA   Song Z., Hao X., Chen Q.;
RT   "A small natural molecule promotes mitochondrial fusion through inhibition
RT   of the deubiquitinase USP30.";
RL   Cell Res. 24:482-496(2014).
CC   -!- FUNCTION: Mitochondrial outer membrane GTPase that mediates
CC       mitochondrial clustering and fusion (PubMed:12527753, PubMed:23921378,
CC       PubMed:23620051). Mitochondria are highly dynamic organelles, and their
CC       morphology is determined by the equilibrium between mitochondrial
CC       fusion and fission events. Overexpression induces the formation of
CC       mitochondrial networks. Membrane clustering requires GTPase activity
CC       and may involve a major rearrangement of the coiled coil domains (By
CC       similarity). Plays a central role in mitochondrial metabolism and may
CC       be associated with obesity and/or apoptosis processes. Plays an
CC       important role in the regulation of vascular smooth muscle cell
CC       proliferation (By similarity). Involved in the clearance of damaged
CC       mitochondria via selective autophagy (mitophagy). Is required for PRKN
CC       recruitment to dysfunctional mitochondria (PubMed:23620051). Involved
CC       in the control of unfolded protein response (UPR) upon ER stress
CC       including activation of apoptosis and autophagy during ER stress
CC       (PubMed:23921556). Acts as an upstream regulator of EIF2AK3 and
CC       suppresses EIF2AK3 activation under basal conditions (PubMed:23921556).
CC       {ECO:0000250|UniProtKB:O95140, ECO:0000250|UniProtKB:Q8R500,
CC       ECO:0000269|PubMed:12527753, ECO:0000269|PubMed:23620051,
CC       ECO:0000269|PubMed:23921378, ECO:0000269|PubMed:23921556}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=GTP + H2O = GDP + H(+) + phosphate; Xref=Rhea:RHEA:19669,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:37565,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:58189;
CC         Evidence={ECO:0000250|UniProtKB:O95140};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:19670;
CC         Evidence={ECO:0000250|UniProtKB:O95140};
CC   -!- SUBUNIT: Forms homomultimers and heteromultimers with MFN1
CC       (PubMed:12527753). Oligomerization is essential for mitochondrion
CC       fusion (Probable). Interacts with VAT1 (By similarity). Interacts with
CC       STOML2; may form heterooligomers (By similarity). Interacts
CC       (phosphorylated) with PRKN (PubMed:23620051). Interacts with EIF2AK3
CC       (By similarity). Interacts with THG1L; THG1L probably functions as a
CC       guanyl-nucleotide exchange factor/GEF, activating MFN2.
CC       {ECO:0000250|UniProtKB:O95140, ECO:0000250|UniProtKB:Q8R500,
CC       ECO:0000269|PubMed:23620051, ECO:0000269|PubMed:23921556, ECO:0000305}.
CC   -!- INTERACTION:
CC       Q80U63; O08734: Bak1; NbExp=2; IntAct=EBI-8437663, EBI-822441;
CC       Q80U63; Q9Z2B5: Eif2ak3; NbExp=2; IntAct=EBI-8437663, EBI-1226344;
CC       Q80U63; Q16611: BAK1; Xeno; NbExp=3; IntAct=EBI-8437663, EBI-519866;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion outer membrane
CC       {ECO:0000250|UniProtKB:O95140}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:O95140}. Note=Colocalizes with BAX during
CC       apoptosis. {ECO:0000250|UniProtKB:O95140}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q80U63-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q80U63-2; Sequence=VSP_010365, VSP_010366;
CC   -!- TISSUE SPECIFICITY: Ubiquitous. Expression is markedly reduced in ApoE-
CC       knockout mouse atherosclerotic arteries. {ECO:0000269|PubMed:11950885,
CC       ECO:0000269|PubMed:15322553}.
CC   -!- DOMAIN: A helix bundle is formed by helices from the N-terminal and the
CC       C-terminal part of the protein. The GTPase domain cannot be expressed
CC       by itself, without the helix bundle. Rearrangement of the helix bundle
CC       and/or of the coiled coil domains may bring membranes from adjacent
CC       mitochondria into close contact, and thereby play a role in
CC       mitochondrial fusion. {ECO:0000250|UniProtKB:Q8IWA4}.
CC   -!- PTM: Phosphorylated by PINK1. {ECO:0000269|PubMed:23620051}.
CC   -!- PTM: Ubiquitinated by non-degradative ubiquitin by PRKN, promoting
CC       mitochondrial fusion; deubiquitination by USP30 inhibits mitochondrial
CC       fusion (PubMed:23620051, PubMed:24513856). Ubiquitinated by HUWE1 when
CC       dietary stearate (C18:0) levels are low; ubiquitination inhibits
CC       mitochondrial fusion (By similarity). {ECO:0000250|UniProtKB:O95140,
CC       ECO:0000269|PubMed:23620051, ECO:0000269|PubMed:24513856}.
CC   -!- DISRUPTION PHENOTYPE: Mutant mice die early during embryonic
CC       development (PubMed:12527753). Heart-specific disruption causes
CC       cardiomyopathy in aging mice, characterized by dilated hearts that are
CC       insensitive to beta-adrenergic stimulation and impaired contractile
CC       performance (PubMed:23620051). Mutant cardiomyocytes display
CC       mitochondrial enlargement with respiratory impairment
CC       (PubMed:23620051). {ECO:0000269|PubMed:23620051}.
CC   -!- SIMILARITY: Belongs to the TRAFAC class dynamin-like GTPase
CC       superfamily. Dynamin/Fzo/YdjA family. Mitofusin subfamily.
CC       {ECO:0000255|PROSITE-ProRule:PRU01055}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAC65502.2; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY123975; AAM88577.1; -; mRNA.
DR   EMBL; AY028170; AAK27416.1; -; mRNA.
DR   EMBL; AB048831; BAB39351.1; -; mRNA.
DR   EMBL; AF384100; AAK66559.1; -; mRNA.
DR   EMBL; AK042080; BAE20620.1; -; mRNA.
DR   EMBL; AK049583; BAC33826.1; -; mRNA.
DR   EMBL; AK052689; BAC35096.1; -; mRNA.
DR   EMBL; AK122220; BAC65502.2; ALT_INIT; Transcribed_RNA.
DR   EMBL; AL607066; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC046503; AAH46503.1; -; mRNA.
DR   CCDS; CCDS38965.1; -. [Q80U63-1]
DR   RefSeq; NP_001272849.1; NM_001285920.1. [Q80U63-1]
DR   RefSeq; NP_001272850.1; NM_001285921.1. [Q80U63-1]
DR   RefSeq; NP_001272851.1; NM_001285922.1. [Q80U63-1]
DR   RefSeq; NP_001272852.1; NM_001285923.1. [Q80U63-1]
DR   RefSeq; NP_573464.2; NM_133201.3. [Q80U63-1]
DR   RefSeq; XP_006538672.1; XM_006538609.3. [Q80U63-1]
DR   RefSeq; XP_006538673.1; XM_006538610.2.
DR   RefSeq; XP_006538674.1; XM_006538611.3.
DR   AlphaFoldDB; Q80U63; -.
DR   SMR; Q80U63; -.
DR   BioGRID; 228398; 10.
DR   DIP; DIP-60970N; -.
DR   IntAct; Q80U63; 8.
DR   MINT; Q80U63; -.
DR   STRING; 10090.ENSMUSP00000101341; -.
DR   GuidetoPHARMACOLOGY; 3131; -.
DR   iPTMnet; Q80U63; -.
DR   PhosphoSitePlus; Q80U63; -.
DR   EPD; Q80U63; -.
DR   jPOST; Q80U63; -.
DR   MaxQB; Q80U63; -.
DR   PaxDb; Q80U63; -.
DR   PeptideAtlas; Q80U63; -.
DR   PRIDE; Q80U63; -.
DR   ProteomicsDB; 295893; -. [Q80U63-1]
DR   ProteomicsDB; 295894; -. [Q80U63-2]
DR   ABCD; Q80U63; 1 sequenced antibody.
DR   Antibodypedia; 28394; 762 antibodies from 45 providers.
DR   DNASU; 170731; -.
DR   Ensembl; ENSMUST00000030884; ENSMUSP00000030884; ENSMUSG00000029020. [Q80U63-1]
DR   Ensembl; ENSMUST00000105714; ENSMUSP00000101339; ENSMUSG00000029020. [Q80U63-2]
DR   Ensembl; ENSMUST00000105715; ENSMUSP00000101340; ENSMUSG00000029020. [Q80U63-1]
DR   Ensembl; ENSMUST00000105716; ENSMUSP00000101341; ENSMUSG00000029020. [Q80U63-1]
DR   GeneID; 170731; -.
DR   KEGG; mmu:170731; -.
DR   UCSC; uc008vtg.2; mouse. [Q80U63-1]
DR   UCSC; uc008vtj.2; mouse. [Q80U63-2]
DR   CTD; 9927; -.
DR   MGI; MGI:2442230; Mfn2.
DR   VEuPathDB; HostDB:ENSMUSG00000029020; -.
DR   eggNOG; KOG0448; Eukaryota.
DR   GeneTree; ENSGT00390000013727; -.
DR   HOGENOM; CLU_021212_2_0_1; -.
DR   InParanoid; Q80U63; -.
DR   OMA; LEFRFSF; -.
DR   OrthoDB; 216494at2759; -.
DR   PhylomeDB; Q80U63; -.
DR   TreeFam; TF314289; -.
DR   Reactome; R-MMU-5205685; PINK1-PRKN Mediated Mitophagy.
DR   Reactome; R-MMU-9013419; RHOT2 GTPase cycle.
DR   Reactome; R-MMU-983231; Factors involved in megakaryocyte development and platelet production.
DR   BioGRID-ORCS; 170731; 14 hits in 74 CRISPR screens.
DR   ChiTaRS; Mfn2; mouse.
DR   PRO; PR:Q80U63; -.
DR   Proteomes; UP000000589; Chromosome 4.
DR   RNAct; Q80U63; protein.
DR   Bgee; ENSMUSG00000029020; Expressed in interventricular septum and 253 other tissues.
DR   ExpressionAtlas; Q80U63; baseline and differential.
DR   Genevisible; Q80U63; MM.
DR   GO; GO:0005737; C:cytoplasm; ISO:MGI.
DR   GO; GO:0005829; C:cytosol; ISS:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0031306; C:intrinsic component of mitochondrial outer membrane; ISS:UniProtKB.
DR   GO; GO:0015630; C:microtubule cytoskeleton; IDA:MGI.
DR   GO; GO:0005741; C:mitochondrial outer membrane; ISO:MGI.
DR   GO; GO:0005739; C:mitochondrion; IDA:MGI.
DR   GO; GO:0005525; F:GTP binding; ISO:MGI.
DR   GO; GO:0003924; F:GTPase activity; IBA:GO_Central.
DR   GO; GO:0051020; F:GTPase binding; ISO:MGI.
DR   GO; GO:0042802; F:identical protein binding; ISO:MGI.
DR   GO; GO:0043394; F:proteoglycan binding; ISO:MGI.
DR   GO; GO:0031267; F:small GTPase binding; ISO:MGI.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; ISO:MGI.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0001825; P:blastocyst formation; IMP:MGI.
DR   GO; GO:0048593; P:camera-type eye morphogenesis; IMP:MGI.
DR   GO; GO:0048312; P:intracellular distribution of mitochondria; ISO:MGI.
DR   GO; GO:0051560; P:mitochondrial calcium ion homeostasis; ISO:MGI.
DR   GO; GO:0008053; P:mitochondrial fusion; IMP:UniProtKB.
DR   GO; GO:0007006; P:mitochondrial membrane organization; ISS:UniProtKB.
DR   GO; GO:0051646; P:mitochondrion localization; ISS:UniProtKB.
DR   GO; GO:0070584; P:mitochondrion morphogenesis; ISO:MGI.
DR   GO; GO:0007005; P:mitochondrion organization; ISO:MGI.
DR   GO; GO:0010667; P:negative regulation of cardiac muscle cell apoptotic process; ISO:MGI.
DR   GO; GO:0045786; P:negative regulation of cell cycle; ISO:MGI.
DR   GO; GO:0060548; P:negative regulation of cell death; ISO:MGI.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; ISO:MGI.
DR   GO; GO:0045792; P:negative regulation of cell size; ISO:MGI.
DR   GO; GO:0060253; P:negative regulation of glial cell proliferation; ISO:MGI.
DR   GO; GO:0090258; P:negative regulation of mitochondrial fission; ISO:MGI.
DR   GO; GO:1901215; P:negative regulation of neuron death; ISO:MGI.
DR   GO; GO:0046580; P:negative regulation of Ras protein signal transduction; ISO:MGI.
DR   GO; GO:1903427; P:negative regulation of reactive oxygen species biosynthetic process; ISO:MGI.
DR   GO; GO:0090201; P:negative regulation of release of cytochrome c from mitochondria; ISO:MGI.
DR   GO; GO:0060299; P:negative regulation of sarcomere organization; ISO:MGI.
DR   GO; GO:0048662; P:negative regulation of smooth muscle cell proliferation; ISS:UniProtKB.
DR   GO; GO:1904706; P:negative regulation of vascular associated smooth muscle cell proliferation; ISO:MGI.
DR   GO; GO:0061734; P:parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization; IMP:ParkinsonsUK-UCL.
DR   GO; GO:1901857; P:positive regulation of cellular respiration; ISO:MGI.
DR   GO; GO:0035563; P:positive regulation of chromatin binding; ISO:MGI.
DR   GO; GO:0120162; P:positive regulation of cold-induced thermogenesis; IMP:YuBioLab.
DR   GO; GO:0061003; P:positive regulation of dendritic spine morphogenesis; ISO:MGI.
DR   GO; GO:2000866; P:positive regulation of estradiol secretion; ISO:MGI.
DR   GO; GO:0010628; P:positive regulation of gene expression; ISO:MGI.
DR   GO; GO:0046326; P:positive regulation of glucose import; ISO:MGI.
DR   GO; GO:0010729; P:positive regulation of hydrogen peroxide biosynthetic process; ISO:MGI.
DR   GO; GO:0046628; P:positive regulation of insulin receptor signaling pathway; ISO:MGI.
DR   GO; GO:0010918; P:positive regulation of mitochondrial membrane potential; ISO:MGI.
DR   GO; GO:2000386; P:positive regulation of ovarian follicle development; ISO:MGI.
DR   GO; GO:2000872; P:positive regulation of progesterone secretion; ISO:MGI.
DR   GO; GO:1903428; P:positive regulation of reactive oxygen species biosynthetic process; ISO:MGI.
DR   GO; GO:1905461; P:positive regulation of vascular associated smooth muscle cell apoptotic process; ISO:MGI.
DR   GO; GO:1904707; P:positive regulation of vascular associated smooth muscle cell proliferation; ISO:MGI.
DR   GO; GO:0034497; P:protein localization to phagophore assembly site; ISO:MGI.
DR   GO; GO:0006626; P:protein targeting to mitochondrion; ISS:UniProtKB.
DR   GO; GO:0006986; P:response to unfolded protein; IEA:UniProtKB-KW.
DR   Gene3D; 3.40.50.300; -; 1.
DR   InterPro; IPR045063; Dynamin_N.
DR   InterPro; IPR006884; Fzo/mitofusin_HR2.
DR   InterPro; IPR030381; G_DYNAMIN_dom.
DR   InterPro; IPR027089; Mitofusin-2.
DR   InterPro; IPR027094; Mitofusin_fam.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR10465; PTHR10465; 1.
DR   PANTHER; PTHR10465:SF1; PTHR10465:SF1; 1.
DR   Pfam; PF00350; Dynamin_N; 1.
DR   Pfam; PF04799; Fzo_mitofusin; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS51718; G_DYNAMIN_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Apoptosis; Autophagy; Coiled coil;
KW   Developmental protein; Direct protein sequencing; GTP-binding; Hydrolase;
KW   Membrane; Mitochondrion; Mitochondrion outer membrane; Nucleotide-binding;
KW   Phosphoprotein; Reference proteome; Transmembrane; Transmembrane helix;
KW   Ubl conjugation; Unfolded protein response.
FT   CHAIN           1..757
FT                   /note="Mitofusin-2"
FT                   /id="PRO_0000127676"
FT   TOPO_DOM        1..604
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        605..625
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        626
FT                   /note="Mitochondrial intermembrane"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        627..647
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        648..757
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          93..342
FT                   /note="Dynamin-type G"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01055"
FT   REGION          30..94
FT                   /note="Part of a helix bundle domain, formed by helices
FT                   from N-terminal and C-terminal regions"
FT                   /evidence="ECO:0000250|UniProtKB:Q8IWA4"
FT   REGION          103..110
FT                   /note="G1 motif"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01055"
FT   REGION          129..130
FT                   /note="G2 motif"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01055"
FT   REGION          199..202
FT                   /note="G3 motif"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01055"
FT   REGION          258..261
FT                   /note="G4 motif"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01055"
FT   REGION          288
FT                   /note="G5 motif"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01055"
FT   REGION          359..385
FT                   /note="Part of a helix bundle domain, formed by helices
FT                   from N-terminal and C-terminal regions"
FT                   /evidence="ECO:0000250|UniProtKB:Q8IWA4"
FT   REGION          722..753
FT                   /note="Part of a helix bundle domain, formed by helices
FT                   from N-terminal and C-terminal regions"
FT                   /evidence="ECO:0000250|UniProtKB:Q8IWA4"
FT   COILED          406..434
FT                   /evidence="ECO:0000255"
FT   COILED          696..738
FT                   /evidence="ECO:0000255"
FT   BINDING         106..111
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250|UniProtKB:Q8IWA4"
FT   BINDING         258..261
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250|UniProtKB:Q8IWA4"
FT   BINDING         305
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250|UniProtKB:Q8IWA4"
FT   BINDING         307
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250|UniProtKB:Q8IWA4"
FT   MOD_RES         111
FT                   /note="Phosphothreonine; by PINK1"
FT                   /evidence="ECO:0000250|UniProtKB:O95140"
FT   MOD_RES         442
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   VAR_SEQ         573..605
FT                   /note="VQRPLPLTPANPSMPPLPQSSLTQEELMVSMVT -> ARSSFPWCIMGDHPD
FT                   TRYGSQSTTAGVLRAEAI (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:16141072"
FT                   /id="VSP_010365"
FT   VAR_SEQ         606..757
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:16141072"
FT                   /id="VSP_010366"
FT   CONFLICT        123
FT                   /note="P -> L (in Ref. 9; AAH46503)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        167
FT                   /note="L -> I (in Ref. 7; BAC33826)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        332
FT                   /note="Q -> K (in Ref. 2; AAK27416)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        344
FT                   /note="Q -> R (in Ref. 3; BAB39351 and 4; AAK66559)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        437
FT                   /note="E -> G (in Ref. 3; BAB39351)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        570
FT                   /note="S -> N (in Ref. 2; AAK27416)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        592
FT                   /note="S -> G (in Ref. 2; AAK27416)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        601
FT                   /note="V -> G (in Ref. 2; AAK27416)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        633..635
FT                   /note="LIA -> IIP (in Ref. 2; AAK27416)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        656
FT                   /note="A -> T (in Ref. 2; AAK27416)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        659
FT                   /note="R -> K (in Ref. 2; AAK27416)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        666
FT                   /note="V -> A (in Ref. 4; AAK66559)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        667
FT                   /note="E -> D (in Ref. 3; BAB39351)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        676
FT                   /note="I -> T (in Ref. 3; BAB39351)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        697
FT                   /note="A -> G (in Ref. 2; AAK27416)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        730
FT                   /note="R -> K (in Ref. 2; AAK27416)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   757 AA;  86188 MW;  25B0EAE8301F4D1A CRC64;
     MSLLFSRCNS IVTVKKDKRH MAEVNASPLK HFVTAKKKIN GIFEQLGAYI QESASFLEDT
     HRNTELDPVT TEEQVLDVKG YLSKVRGISE VLARRHMKVA FFGRTSNGKS TVINAMLWDK
     VLPSGIGHTT NCFLRVGGTD GHEAFLLTEG SEEKKSVKTV NQLAHALHQD EQLHAGSMVS
     VMWPNSKCPL LKDDLVLMDS PGIDVTTELD SWIDKFCLDA DVFVLVANSE STLMQTEKQF
     FHKVSERLSR PNIFILNNRW DASASEPEYM EEVRRQHMER CTSFLVDELG VVDRAQAGDR
     IFFVSAKEVL SARVQKAQGM PEGGGALAEG FQVRMFEFQN FERQFEECIS QSAVKTKFEQ
     HTVRAKQIAE AVRLIMDSLH IAAQEQRVYC LEMREERQDR LRFIDKQLEL LAQDYKLRIK
     QITEEVERQV STAMAEEIRR LSVLVDEYQM DFHPSPVVLK VYKNELHRHI EEGLGRNLSD
     RCSTAIASSL QTMQQDMIDG LKPLLPVSMR NQIDMLVPRQ CFSLSYDLNC DKLCADFQED
     IEFHFSLGWT MLVNRFLGPK NSRRALLGYS DQVQRPLPLT PANPSMPPLP QSSLTQEELM
     VSMVTGLASL TSRTSMGILV VGGVVWKAVG WRLIALSFGL YGLLYVYERL TWTTKAKERA
     FKRQFVEYAS EKLQLIISYT GSNCSHQVQQ ELSGTFAHLC QQVDITRDNL EQEIAAMNKK
     VEALDSLQSR AKLLRNKAGW LDSELNMFTH QYLQPSR
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024